Trexquant Investment’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Trexquant Investment’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-6,769	Closed	-$494K	–	1446
2017 Q4	$494K	Buy	6,769 +5,143	+316%	+$425K	0.05%	517
2017 Q3	$149K	Sell	1,626 -389	-19%	-$29.8K	0.04%	691
2017 Q2	$133K	Buy	2,015 +567	+39%	+$70.2K	0.04%	719
2017 Q1	$314K	Sell	1,448 -717	-33%	-$102K	0.04%	736
2016 Q4	$200K	Buy	+2,165	New	+$244K	0.03%	825
2015 Q4	–	Sell	-644	Closed	-$206K	–	1311
2015 Q3	$206K	Buy	+644	New	+$283K	0.02%	966
2015 Q2	–	Sell	-551	Closed	-$270K	–	1289
2015 Q1	$270K	Buy	+551	New	+$214K	0.03%	860

Other funds holding LUMO

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Trexquant Investment's LUMO Position: Q1 2018 in Review

Trexquant Investment sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q1 2018, closing a stake of 6,769 shares — an estimated $494K sold.

Trexquant Investment first reported a position in LUMO in Q1 2015 and held it in 7 quarters. The position peaked at $494K in Q4 2017. 126 funds tracked by Wall St. Rank hold LUMO as of Q1 2018.

Trexquant Investment reported no remaining Lumos Pharma, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Trexquant Investment sold 6,769 Lumos Pharma, Inc. Common Stock shares in Q1 2018, an estimated $494K.
Trexquant Investment first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2015 and held it in 7 quarters.
Trexquant Investment's Lumos Pharma, Inc. Common Stock position peaked at $494K in Q4 2017.
126 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q1 2018.

Based on Trexquant Investment's 13F filing for Q1 2018, filed 3 May 2018.